Gynecological Devices - Market Insights, Competitive Landscape, and Market Forecast - 2028

The market is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of various gynecological ailments and increasing figure of surgical procedures across the globe.

The global gynecological devices market is estimated to grow at a CAGR of 8.37% during the forecast period from 2023 to 2028. The demand for gynecological devices is primarily being boosted by the increasing figures of gynecological disorders such as cervical dysplasia, pelvic floor prolapse, adnexal tumors, endometriosis, ovarian cysts, uterine fibroids, and others. Further, the rising adoption of advanced and innovative technologies, increasing demand for minimally invasive therapy, rising demand for birth control devices and surgeries, rising awareness about family planning and birth control, and increasing product launches and approval among others are thereby contributing to the overall growth of the gynecological devices market during the forecast period from 2023-2028.

Gynecological Devices Market Dynamics:

The increase in the prevalence of various gynecological disorders such as cervical dysplasia, pelvic floor prolapse, adnexal tumors, endometriosis, ovarian cysts, uterine fibroids, and others. According to World Health Organization (WHO) 2020, 2020 nearly 314 thousand new cases of ovarian cancer were reported globally. Thus, the high incidence rate of cancer could be controlled through a comprehensive approach that includes prevention, early diagnosis, effective screening, and treatment programs. This, in turn, leads to high demand for gynecological devices such as endoscopic devices, and diagnostic imaging devices, among others globally.

Furthermore, the growing number of surgical procedures, such as female sterilization, ablation, endoscopy, and laparoscopy, as well as the increased use of disposable products, are expected to drive product demand. The increasing adoption of cutting-edge and innovative technologies is also expected to drive industry growth. Endoluxe, a California-based company, for example, launched Endoluxe eVS, an HD wireless endoscopic camera equipped with TowerTech for gynecological, urological, ENT, orthopedics, and general surgery in March 2022. The market is heavily regulated to improve and ensure the safety of the devices.

An upsurge in the figure of unintended pregnancies in unsafe abortions or some gynecological conditions. This has led to an increase in gynecological surgical volumes globally. According to the United Nations 2022, each year, around 60% of pregnancies globally are unintended and around 45% of unintended pregnancies lead to unsafe abortion.

Lastly, the increasing awareness regarding gynecological health is a major fuelling factor for the market growth. For instance, in September 2022, the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research presented the 'Virtual Ovarian Cancer Research Series'. The goal of the seminar series was to bring together clinicians and researchers from across many disciplines and institutions worldwide to share ideas and advance the field of ovarian cancer research.

Therefore, the above-mentioned factors are contributing to the growth of the gynecological devices market during the forecast period from 2023-2028.

However, stringent regulatory guidelines, complications related to various devices, and others may restrict the gynecological devices market growth.

Gynecological Devices Market Segment Analysis:

Gynecological Devices by Product (Gynecological Endoscopy Devices [Hysteroscope, Resectoscope, and Others), Endometrial Ablation Devices [Balloon Ablation Devices, Radiofrequency Ablation Devices, and Others], Contraceptive Devices [Temporary Birth Control and Permanent Birth Control], Diagnostic Imaging Systems, Fluid Management Systems, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the gynecological devices market, the balloon ablation devices category is expected to amass significant revenue share in the year 2022. This can be ascribed to the increasing prevalence of endometrial cancer and the rising adoption of these devices due to their ease of use and convenience.

The WHO in 2020 stated that endometrial (also known as womb or corpus uteri) cancer is the 6th most common cancer in women and the 15th most common cancer overall. The source added that cervix uteri cancer accounted for 604 thousand new cases in 2020, globally. The source also stated that in 2040 nearly 798 thousand new cases of corpus uteri will be reported, across the world.

Also, the advantages of endometrial balloon ablation over other surgical techniques include quicker recovery times, less discomfort, minimal invasion, and shorter operating times.

The increasing technological advancements in balloon ablation devices will also impact the demand of the segment. For instance, modified thermal balloon ablation devices with a catheter are likely to be the best treatment option in the management of heavy menstrual bleeding.

Therefore, the advantages offered by balloon ablation devices are predicted to contribute to the increasing demand for this product type thereby driving the growth of the overall gynecological devices market during the forecast period.

North America is expected to dominate the overall Gynecological Devices Market:

Among all the regions, North America is estimated to account for the largest share of the gynecological devices market in the year 2022. Owing to the significance of key growth factors rising prevalence of ovarian and cervical cancers, the growing prevalence of sexually transmitted diseases, rising use of contraceptive devices, is driving the North America gynecological devices market and are expected to witness positive growth. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new products, and high awareness also helped the market growth in this region.

The American Cancer Society estimated that nearly 19,710 new diagnoses of ovarian cancer will be reported in the United States in 2023. The same source also reported that about 13,960 new cases of invasive cervical cancer will be diagnosed in the United States in 2023. The increasing incidence of cervical and ovarian cancer will increase the number of diagnoses and treatment procedures that will be done by various gynecological devices such as endoscopy, ablation, and others. Thus, the increasing prevalence of cancers will increase the demand for gynecological devices, thereby propelling the overall market of gynecological devices.

The increasing prevalence of sexually transmitted diseases and the surging awareness regarding their demand and devices will increase the demand for many gynecological devices such as intrauterine devices (IUD), intravaginal rings, subdermal contraceptive implants, and others. The Centers for Disease Control and Prevention (CDC) 2022, reported that in 2021, approximately 2.5 million cases were reported of chlamydia, gonorrhea, and syphilis 2021.

Coupled with the factors mentioned above, strategic activities such as product launches and approvals, mergers, acquisitions, partnerships, and others also help in boosting regional product demand. For instance, in October 2021, Hologic, Inc., a global leader in women's health, signed a definitive agreement to acquire Bolder Surgical, a privately held, United States-based company that provides advanced energy vessel sealing surgical devices, for approximately USD 160 million, subject to working capital and other customary closing adjustments. The complementary acquisition of Bolder Surgical is likely to add to Hologic's surgical product line, which includes the NovaSure, an endometrial ablation system for the treatment of abnormal uterine bleeding, the MyoSure, tissue removal devices for the treatment of intrauterine fibroids and polyps, the Acessa laparoscopic radiofrequency ablation system for the treatment of fibroids, and the Fluent, fluid management system for streamlining hysteroscopic procedures. Thus, such strategic steps help to increase the demand for gynecological devices, thereby driving the North America gynecological devices market forward during the forecast period.

Gynecological Devices Market Key Players:

Some of the key market players operating in the gynecological devices market include Boston Scientific Corporation, Hologic, Inc., Medtronic, Olympus America, Stryker, UroViu Corporation, Medical Device Business Services, Inc., Karl Storz SE & Co. KG, Richard Wolf GmbH., COOPER SURGICAL, INC., MEDGYN PRODUCTS, INC., Minerva Surgical, Inc., Veldana Medical SA, Veru Inc., Teva Pharmaceutical Industries Ltd, Cupid Limited, Merck & Co Inc., Meril Life Sciences Pvt. Ltd, Pregna International Limited, Odyssea Pharma SPR, and others.

Recent Developmental Activities in the Gynecological Devices Market:

• In June 2022, UroViu Corp launched the new Hystero-V, a single-use hysteroscope compatible with UroViu's Always Ready endoscopy platform. The 12-Fr, semi-rigid, Hystero-V features a hydrophilic coating enabling gentle insertion and superior visualization for highly effective intrauterine examinations.
• In February 2022, Mithra and Searchlight Pharma announced the commercial launch of Mithra's vaginal contraceptive ring Myring under the brand name Haloette in Canada.
• In October 2021, Hologic, Inc., a global leader in women's health, launched its expanded Omni® suite, a comprehensive gynecological surgical offering designed to optimize diagnostic and operative hysteroscopy, in Europe, Africa, and the Middle East (EMEA). The offering now includes a versatile Omni 30° hysteroscope, the Omni Lok cervical seal, and the Omni 5 French seal, which complement the company's existing portfolio of GYN surgical solutions and extend physicians' choices.
• In November 2021, Hologic, Inc., a global leader in women's health, launched the NovaSure V5 global endometrial ablation (GEA) device.

Key Takeaways from the Gynecological Devices Market Report Study

• Market size analysis for current gynecological devices market size (2022), and market forecast for 5 years (2023-2028)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the gynecological devices market.
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the global gynecological devices market.
• Various opportunities available for the other competitor in the gynecological devices market space.
• What are the top-performing segments in 2022? How these segments will perform in 2028.
• Which are the top-performing regions and countries in the current gynecological devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for gynecological devices market growth in the coming future?

Target Audience who can be benefited from this Gynecological Devices Market Report Study

• Gynecological devices products providers
• Research organizations and consulting companies
• Gynecological devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in gynecological devices
• Various End-users who want to know more about the gynecological devices market and the latest technological developments in the gynecological devices market.

Frequently Asked Questions for the Gynecological Devices Market:

1. What are gynecological devices?

Gynecological devices refer to surgical and monitoring devices used for gynecological conditions and disorders, such as fluid management, endometrial ablation, gynecological endoscopy, and contraceptive devices.

2. What is the market for global gynecological devices?

The global gynecological devices market is estimated to grow at a CAGR of 8.37% during the forecast period from 2023 to 2028.

3. What are the drivers for the global gynecological devices market?

The demand for gynecological devices is primarily being heightened by the increasing prevalence of gynecological disorders such as cervical dysplasia, pelvic floor prolapse, adnexal tumors, endometriosis, ovarian cysts, uterine fibroids, and others. In addition, the advancement in gynecological devices that aid in improving the efficiency of the minimally invasive technique for surgeries and the development of advanced imaging devices, such as 3D endoscopes, increasing device launches and approvals, among others thereby contribute to the overall growth of the gynecological devices market during the forecast period from 2023-2028.

4. Who are the key players operating in the global gynecological devices market?

Some of the key market players operating in the gynecological devices market include Boston Scientific Corporation, Hologic, Inc., Medtronic, Olympus America, Stryker, UroViu Corporation, Medical Device Business Services, Inc., Karl Storz SE & Co. KG, Richard Wolf GmbH., COOPER SURGICAL, INC., MEDGYN PRODUCTS, INC., Minerva Surgical, Inc., Veldana Medical SA, Veru Inc., Teva Pharmaceutical Industries Ltd, Cupid Limited, Merck & Co Inc., Meril Life Sciences Pvt. Ltd, Pregna International Limited, Odyssea Pharma SPR, and others.

5. Which region has the highest share in the gynecological devices market?

North America is expected to dominate the overall gynecological devices market during the forecast period from 2023-2028. Factors such as the rising prevalence of gynecological disorders such as ovarian and cervical cancers, the growing prevalence of sexually transmitted diseases, the rising use of contraceptives, a type of gynecological device amongst females, the North American gynecological devices market is expected to witness positive growth. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about gynecological diseases also helped the market growth in this region.


This product will be delivered within 3-5 business days.